https://www.clinicaltrialsarena.com/news/newsamgen-begins-phase-i-trial-of-talimogene-laherparepvec-and-keytruda-to-treat-melanoma-4463198/
Amgen has started a Phase I trial of its investigational oncolytic immunotherapy 'talimogene laherparepvec' to treat patients with regionally or distantly...
talimogene laherparepvecamgenbeginsphasetrial